ASX
Neuren Pharmaceuticals Limited
NEU:ASX•Healthcare
Sensitive ASX Announcement
Update on trofinetide Phase 3 trial in Rett syndrome
Published: 19/02/20, 12:41pm (AEST)•2 pages